Skip to main content
OpenTrials

Clinical trial condition

Adnexal Diseases

Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.

3,502 public trials 676 recruiting studies
Refine in advanced search Browse all conditions

Adnexal Diseases trial results

Active, Not Recruiting

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

NCT01844986

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, BRCA Mutation, +24 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 177 locations
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, Not Recruiting

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

NCT05973487

Conditions
Adnexal Diseases, Anogenital Cancers, Cervical Cancer, +47 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

NCT04180371

Conditions
Adnexal Diseases, Advanced Solid Tumor Historically Known for High EphA2 Expression, Breast Diseases, +49 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Encinitas, California, United States
  • University of California - Irvine Medical Center Orange, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

NCT04561362

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +30 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Ocala Oncology Center Ocala, Florida, United States
  • Advent Health Orlando, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details

Related conditions